相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Vesicular Monoamine Transporter 2, C-terminus (VMAT2)
- 形态:
100 µl in 10 mM HEPES (pH 7.5), 150 mM NaCl, 100 µg per ml BSA and 50% glycerol.
- 保存条件:
-20 C
- 克隆性:
单克隆
- 适应物种:
rat
- 抗原来源:
human
- 库存:
1
- 供应商:
北京博蕾德生物科技有限公司
- 宿主:
Sheep
- 应用范围:
WB
- 靶点:
Vesicular Monoamine Transporter 2, C-terminus (VMAT2)
- 抗体英文名:
Vesicular Monoamine Transporter 2, C-terminus (VMAT2) antibody
- 抗体名:
Vesicular Monoamine Transporter 2, C-terminus (VMAT2) antibody
- 规格:
100µL
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验alleles (homozygote). This procedure has been used to generate animals lacking either the plasma membrane dopamine transporter (DAT; Fig. 2 ) or the vesicular monoamine transporter (VMAT2; Fig. 3 ). Both DAT and VMAT2 are essential for dopamine homeostasis
Vesicular monoamine transporters (VMATs) are involved in the presynaptic packaging of monoaminergic neurotransmitters into storage granules. Upon an action potential, vesicles release their contents into the synaptic cleft via exocytosis
Immunochemical Analysis of Dopamine Transporters in Parkinson Disease
to dopamine or tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis, have been used to identify these neurons. Recently, considerable attention has been given to the plasma membrane dopamine tranporter (DAT ) and the vesicular monoamine
技术资料暂无技术资料 索取技术资料











